🥙FDA Seeks Information on Poppy Seed Industry Practices and Safety
Growing, Harvesting, Processing, and Distribution of Poppy Seeds-Industry Practices Related to Opiate Alkaloids; Request for Information
Summary
The Food and Drug Administration (FDA or we) is requesting information on industry practices related to poppy seeds, such as information about growing, harvesting, processing, and distribution of poppy seeds, including industry practices to reduce the opiate alkaloid content of poppy seeds. We are taking this action, in part, because we have received reports of adverse events related to the use of some poppy seed products. We intend to use the information to help determine what type(s) of actions, if any, we should take to help ensure that poppy seed products do not pose a health risk when consumed.
Agencies
- Health and Human Services Department
- Food and Drug Administration
Business Impact
$$ - Med
The FDA's request for information regarding practices related to poppy seeds directly impacts compliance and regulatory requirements for businesses in the agricultural and food production sectors. Companies must assess current practices and may need to implement changes based on findings that could affect product safety and marketability.